Cart (0)
No products in the cart.
Purchase CAS:1253924-71-8 | 4-Oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-ene, 4-(4-Oxo-1,3,8-triazaspiro[4.5]dec-1-en-2-yl)-alpha,alpha,alpha-trifluoroanisole,view related peer-reviewed papers,technical documents,similar products,MSDS & more.The compound “2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one” is a complex organic molecule. It contains a trifluoromethoxy group attached to a phenyl ring, which is then attached to a triazaspirodecenone ring. The trifluoromethoxy group is a strong electron-withdrawing group, w...
The compound “2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one” is a complex organic molecule. It contains a trifluoromethoxy group attached to a phenyl ring, which is then attached to a triazaspirodecenone ring. The trifluoromethoxy group is a strong electron-withdrawing group, which could influence the reactivity of the compound.
The molecular structure of this compound would be determined by the arrangement of its atoms and the bonds between them. The trifluoromethoxy group would likely have a strong influence on the electronic structure of the molecule due to its electron-withdrawing nature.
The chemical reactions that this compound might undergo would depend on its exact structure and the conditions under which it is reacted. The trifluoromethoxy group could potentially make the phenyl ring more susceptible to electrophilic aromatic substitution reactions.
The physical and chemical properties of this compound would be influenced by its molecular structure. For example, the presence of the trifluoromethoxy group could increase its polarity, potentially affecting its solubility in different solvents.
2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one and its derivatives have been studied extensively as ligands for various receptors. For instance, they have been identified as high-affinity ligands for the human ORL1 (orphanin FQ/nociceptin) receptor, exhibiting full agonist behavior in biochemical assays (Röver et al., 2000) . Such compounds are also noted for their moderate to good selectivity against opioid receptors.
Novel 1,3,8-triazaspiro[4.5]decan-4-one urea derivatives have been synthesized using ultrasound-assisted methods. This approach is noteworthy for its environmental friendliness, energy efficiency, and greater selectivity under ambient conditions (Velupula et al., 2021). These compounds have been characterized by various spectral data, highlighting the versatility and adaptability of this chemical structure in synthesis methodologies.
There has been significant interest in exploring the therapeutic potential of these compounds in cancer treatment. For example, a derivative of this compound demonstrated interesting cytotoxic potential against several human leukemia cell lines (Guillon et al., 2020). This highlights the potential role of these compounds in developing new anticancer therapies.
Certain derivatives of this compound have been explored for their antipsychotic profiles in pharmacological models. For example, one study demonstrated that such derivatives had significant activity in behavioral tests predictive of antipsychotic efficacy, suggesting potential use in treating mental health disorders (Wise et al., 1985).
These compounds have also been evaluated as potential epidermal growth factor receptor inhibitors, with some derivatives displaying potent inhibitory activity. This has implications for their use in targeted cancer therapies, particularly in breast cancer treatment (Fleita et al., 2013).
Some derivatives have been synthesized as potential ligands for dopamine D2 receptors, with applications in imaging studies such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) (Waterhouse et al., 1998). These compounds offer valuable insights into the mapping of dopamine receptors in the brain, contributing significantly to neurological research.
The safety and hazards associated with this compound would depend on its reactivity and biological activity. Without specific data, it’s difficult to provide a detailed safety analysis.
Product Name: | 4-Oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-ene, 4-(4-Oxo-1,3,8-triazaspiro[4.5]dec-1-en-2-yl)-alpha,alpha,alpha-trifluoroanisole |
Synonyms: | 2-[4-(Trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-4-one;4-Oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-ene, 4-(4-Oxo-1,3,8-triazaspiro[4.5]dec-1-en-2-yl)-alpha,alpha,alpha-trifluoroanisole;4-Oxo-2-[4-(trifluoroMethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-ene;2-[4-(TrifluoroMethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-4-one/PD-6;1,3,8-Triazaspiro[4.5]dec-1-en-4-one, 2-[4-(trifluoromethoxy)phenyl]-;2-[4-(Trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-e... |
CAS: | 1253924-71-8 |
MF: | C14H14F3N3O2 |
MW: | 313.28 |
EINECS: | |
Product Categories: | |
Mol File: | 1253924-71-8.mol |
4-Oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-ene, 4-(4-Oxo-1,3,8-triazaspiro[4.5]dec-1-en-2-yl)-alpha,alpha,alpha-trifluoroanisole Chemical Properties |
Boiling point | 380.4±52.0 °C(Predicted) |
density | 1.49±0.1 g/cm3(Predicted) |
storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
pka | 10.67±0.20(Predicted) |